Needle-Free Injectors Market to expand at a 12% value CAGR by 2032Posted by Ganesh Shinde on March 14th, 2023 A recently published study by FMI expects the global needle-free injectors market to augment at a 12% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 42.79 Billion is expected for the market. Faster drug delivery is the key driver for the needle-free injector market. Increasing demand for healthcare sector along with growth in cosmetic surgeries is driving the demand for needle-free injectors. From 2017 to 2021, the industry experienced noteworthy growth, registering a value CAGR of 8% and closing at US$ 12.3 Billion. The use of technologically advanced spring-loaded jet injectors is favoring the growth of the market. In addition, approvals from government authorities to maximize the use of needle-free injectors is accelerating the demand of the same. Geographically, US is the largest contributor to the needle-free injectors market. This is owing to the growing prevalence of chronic diseases in the region. The strong presence of healthcare sectors in Germany, Japan and China too are accelerating the use of needle-free injectors. In the upcoming years, increasing inclination towards minimally invasive surgeries will increase the sales of needle-free injectors. Market Competition Key players in the needle-free injectors market are Gerresheimer AG, Pfizer Inc., Antares Pharma, CSL Limited (Seqirus UK Limited), Crossject, Portal Instruments, Ferring Pharmaceuticals, PharmaJet Inc., PenJet Corporation Browse More@ https://www.futuremarketinsights.com/reports/needle-free-injectors-market Key Segments Profiled In The Needle-Free Injectors Market Industry Survey Needle-Free Injectors Market by Load:
Needle-Free Injectors Market by Technology:
Needle-Free Injectors Market by Delivery Site:
Needle-Free Injectors Market by Application:
Needle-Free Injectors Market by End User:
Like it? Share it!More by this author
|